Literature DB >> 2982030

Inverse relationship between constitutive gamma interferon production and human T-cell lymphoma/leukemia virus expression in cultured T lymphocytes.

J L Moore, B J Poiesz, K W Zamkoff, S A Merl, S Hanna, A F Gazdar, R L Comis.   

Abstract

Particular interest in human T lymphocyte lymphoma/leukemia virus (HTLV) derives from the close association of HTLV with several types of human mature T lymphocyte malignancies and the strong possibility that HTLV is the causative agent of this group of leukemias and lymphomas. This is the first report to show that HTLV expression in T lymphocytes cultured in vitro is inversely proportional to constitutive gamma interferon production. Of 16 fresh T lymphocyte cultures established from patients with mature T lymphocyte neoplasias, 3 were grown continuously for over 3 years and 13 were grown for 2 to 8 months in culture. Of the 16 cultures, 9 were HTLVp19 positive and interferon negative, whereas the remaining 7 were HTLVp19 negative or weakly positive and also interferon positive (12 to 105 U/ml). The prototype HTLV-positive T-cell line (HUT102) was examined over a long-term culture and after selective cell cloning for high virus yield. Results indicate that early-passage, low-HTLV-producing HUT102 cells constitutively produced significant levels of gamma-immune interferon. In late-passage and cloned HUT102 cells, an increase in HTLV production was concordant with a decrease in constitutive interferon production and the loss of mature T lymphocyte antigens. Transformation of human umbilical cord blood lymphocytes by HTLV was possible only after cocultivation with the non-interferon, high virus-producing, cloned HUT102 T lymphocytes. The inverse relationship between interferon and HTLV production was also observed when normal human umbilical cord blood and adult T lymphocytes were transformed by HTLV and maintained in culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982030      PMCID: PMC254655     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.

Authors:  H M Rho; B Poiesz; F W Ruscetti; R C Gallo
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

2.  Immune (gamma) interferon produced by a human T-lymphoblast cell line.

Authors:  I Nathan; J E Groopman; S G Quan; N Bersch; D W Golde
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

3.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

Authors:  B J Poiesz; F W Ruscetti; M S Reitz; V S Kalyanaraman; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

Review 4.  Human T lymphocyte antigens as defined by monoclonal antibodies.

Authors:  B F Haynes
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

5.  Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia.

Authors:  M Robert-Guroff; Y Nakao; K Notake; Y Ito; A Sliski; R C Gallo
Journal:  Science       Date:  1982-02-19       Impact factor: 47.728

6.  Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease.

Authors:  J J Hooks; B F Haynes; B Detrick-Hooks; L F Diehl; T L Gerrard; A S Fauci
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

7.  Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.

Authors:  V S Kalyanaraman; M G Sarngadharan; B Poiesz; F W Ruscetti; R C Gallo
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.

Authors:  M Robert-Guroff; F W Ruscetti; L E Posner; B J Poiesz; R C Gallo
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

10.  Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas.

Authors:  L E Posner; M Robert-Guroff; V S Kalyanaraman; B J Poiesz; F W Ruscetti; B Fossieck; P A Bunn; J D Minna; R C Gallo
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  2 in total

1.  Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).

Authors:  T Oka; Y Ohtsuki; H Sonobe; M Furihata; I Miyoshi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Unique features and clinical importance of acute alloreactive immune responses.

Authors:  Charlotte F Inman; Suzy A Eldershaw; Joanne E Croudace; Nathaniel J Davies; Archana Sharma-Oates; Tanuja Rai; Hayden Pearce; Mirjana Sirovica; Y L Tracey Chan; Kriti Verma; Jianmin Zuo; Sandeep Nagra; Francesca Kinsella; Jane Nunnick; Rasoul Amel-Kashipaz; Charles Craddock; Ram Malladi; Paul Moss
Journal:  JCI Insight       Date:  2018-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.